Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: Results from an Italian biopsy cohort

Abstract Objectives To explore the association of chromogranin A (CgA) levels and the risk of poorly differentiated prostate cancer (CaP) in men undergoing prostate biopsy. Materials and methods Between 2006 and 2012, we prospectively enrolled 1,018 men with no history of CaP undergoing prostate bio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urologic oncology 2014-02, Vol.32 (2), p.80-84
Hauptverfasser: De Nunzio, Cosimo, M.D., Ph.D, Albisinni, Simone, M.D, Presicce, Fabrizio, M.D, Lombardo, Riccardo, M.D, Cancrini, Fabiana, Tubaro, Andrea, M.D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Objectives To explore the association of chromogranin A (CgA) levels and the risk of poorly differentiated prostate cancer (CaP) in men undergoing prostate biopsy. Materials and methods Between 2006 and 2012, we prospectively enrolled 1,018 men with no history of CaP undergoing prostate biopsy. The risk of detecting poorly differentiated CaP as a function of CgA concentration was evaluated using crude and adjusted logistic regressions. Further analyses were performed to determine whether CgA was a significant predictor of high-grade CaP in men with low PSA (
ISSN:1078-1439
1873-2496
DOI:10.1016/j.urolonc.2012.07.012